Macrophage inflammatory signaling

Macrophage inflammatory signaling is a broad biological process encompassing the activation and effector functions of macrophages in response to exogenous and endogenous stimuli (Nature Reviews Immunology, 2017). This signaling is initiated by the binding of ligands to pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which subsequently activate intracellular cascades including the NF-kappaB, MAPK, and JAK-STAT pathways (Frontiers in Immunology, 2020). These pathways culminate in the transcriptional upregulation and secretion of pro-inflammatory mediators like TNF-alpha, IL-1 beta, and IL-6, which are pivotal in the pathogenesis of chronic inflammatory and autoimmune diseases (Journal of Biological Chemistry, 2018). In the context of oncology, dysregulated macrophage signaling contributes to the immunosuppressive tumor microenvironment, promoting tumor growth and metastasis (Cell, 2011). Therapeutic intervention typically targets specific nodes within this signaling network, such as the use of monoclonal antibodies against cytokines or small molecule inhibitors of associated kinases (NIH, 2022). Understanding the nuances of this signaling is critical for developing precision therapies that can modulate immune responses without causing systemic immunosuppression.

Other names

Macrophage activationPro-inflammatory macrophage signalingM1 macrophage polarization signaling

Inhibition of pro-inflammatory cytokine production, blockade of pattern recognition receptors, or modulation of intracellular signaling cascades such as NF-kappaB, MAPK, and JAK-STAT pathways.